-endoxifen not checked

Atossa Therapeutics, Inc.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
2 active
4 in total

What this is

How it works
How it works isn't classified yet
How it’s given
“(Z)-endoxifen capsules. Doses of (Z)-endoxifen to be evaluated include 20 mg (two x 10 mg capsules), 40 mg (one 40 mg capsule) and 80 mg (two x 40 mg capsules).”In the company’s words, NCT05607004 on ClinicalTrials.gov
Tested for
Breast Neoplasms, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer, HER2-negative Breast Cancer, Precocious Puberty, Gonadotropin-dependent
Main trialPhase 2
“This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer. (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells. This study has two parts: a pharmacokinetic part and a treatment part. The PK part (how the body processes the drug) will enroll about 18 participants. All participants will take (Z)-endoxifen capsules daily. Twelve participants will be randomly assigned (50/50 chance) to take (Z)-endoxifen alone or…”In the company’s words, NCT05607004 on ClinicalTrials.gov
Other names
Topical endoxifen

Other drugs for Breast Neoplasms

All 397 drugs for Breast Neoplasms

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 2Active, not recruiting Nov 2026 (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Phase 2Not yet recruiting Jun 2028 (Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty
Phase 2Completed 10 Sep 2018 Topical Endoxifen in Women
Phase 2Completed 14 Jun 2024 Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow -endoxifen

Following is part of Solo: you see every change to -endoxifen the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in